NVAX logo

Novavax (NVAX) Selling, general & administrative expenses

annual SGA:

$337.19M-$131.76M(-28.10%)
December 31, 2024

Summary

  • As of today (May 19, 2025), NVAX annual SGA is $337.19 million, with the most recent change of -$131.76 million (-28.10%) on December 31, 2024.
  • During the last 3 years, NVAX annual SGA has risen by +$38.83 million (+13.01%).
  • NVAX annual SGA is now -31.00% below its all-time high of $488.69 million, reached on December 31, 2022.

Performance

NVAX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

quarterly SGA:

$48.09M-$30.25M(-38.62%)
March 31, 2025

Summary

  • As of today (May 19, 2025), NVAX quarterly SGA is $48.09 million, with the most recent change of -$30.25 million (-38.62%) on March 31, 2025.
  • Over the past year, NVAX quarterly SGA has dropped by -$38.71 million (-44.60%).
  • NVAX quarterly SGA is now -70.25% below its all-time high of $161.66 million, reached on December 31, 2022.

Performance

NVAX quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

TTM SGA:

-$19.23B+$478.70M(+2.43%)
March 31, 2025

Summary

  • As of today (May 19, 2025), NVAX TTM SGA is -$19.23 billion, with the most recent change of +$478.70 million (+2.43%) on March 31, 2025.
  • Over the past year, NVAX TTM SGA has dropped by -$19.68 billion (-4439.19%).
  • NVAX TTM SGA is now -85374.64% below its all-time high of -$22.50 million.

Performance

NVAX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

NVAX Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-28.1%-44.6%-4439.2%
3 y3 years+13.0%-49.9%-5907.4%
5 y5 years+879.7%+412.7%-10000.0%

NVAX Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-31.0%+13.0%-70.3%at low-57.0%+2.4%
5 y5-year-31.0%+879.7%-70.3%+412.7%-239.1%+2.4%
alltimeall time-31.0%>+9999.0%-70.3%>+9999.0%<-9999.0%+2.4%

NVAX Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$48.09M(-38.6%)
$298.48M(-11.5%)
Dec 2024
$337.19M(-28.1%)
$78.34M(+10.7%)
$337.19M(-18.6%)
Sep 2024
-
$70.75M(-30.2%)
$414.08M(-8.1%)
Jun 2024
-
$101.30M(+16.7%)
$450.79M(+1.7%)
Mar 2024
-
$86.80M(-44.1%)
$443.21M(-5.5%)
Dec 2023
$468.95M(-4.0%)
$155.24M(+44.5%)
$468.95M(-1.4%)
Sep 2023
-
$107.46M(+14.7%)
$475.37M(-3.1%)
Jun 2023
-
$93.72M(-16.7%)
$490.79M(-2.9%)
Mar 2023
-
$112.53M(-30.4%)
$505.23M(+3.4%)
Dec 2022
$488.69M(+63.8%)
$161.66M(+31.6%)
$488.69M(+18.8%)
Sep 2022
-
$122.88M(+13.6%)
$411.24M(+12.3%)
Jun 2022
-
$108.16M(+12.7%)
$366.16M(+10.6%)
Mar 2022
-
$95.99M(+14.0%)
$331.16M(+11.0%)
Dec 2021
$298.36M(+105.4%)
$84.21M(+8.3%)
$298.36M(+8.3%)
Sep 2021
-
$77.79M(+6.3%)
$275.46M(+8.2%)
Jun 2021
-
$73.16M(+15.8%)
$254.54M(+27.8%)
Mar 2021
-
$63.19M(+3.1%)
$199.10M(+37.0%)
Dec 2020
$145.29M(+322.1%)
$61.31M(+7.8%)
$145.29M(+57.7%)
Sep 2020
-
$56.88M(+221.0%)
$92.16M(+113.4%)
Jun 2020
-
$17.72M(+88.9%)
$43.18M(+23.1%)
Mar 2020
-
$9.38M(+14.6%)
$35.06M(+1.9%)
Dec 2019
$34.42M(+0.0%)
$8.18M(+3.6%)
$34.42M(-2.9%)
Sep 2019
-
$7.90M(-17.8%)
$35.46M(-1.1%)
Jun 2019
-
$9.61M(+10.0%)
$35.87M(+4.0%)
Mar 2019
-
$8.73M(-5.3%)
$34.49M(+0.2%)
Dec 2018
$34.41M(-0.1%)
$9.22M(+11.0%)
$34.41M(+2.0%)
Sep 2018
-
$8.31M(+1.0%)
$33.73M(+0.6%)
Jun 2018
-
$8.22M(-4.9%)
$33.53M(-2.1%)
Mar 2018
-
$8.65M(+1.3%)
$34.25M(-0.6%)
Dec 2017
$34.45M(-26.0%)
$8.54M(+5.2%)
$34.45M(+0.6%)
Sep 2017
-
$8.12M(-9.2%)
$34.25M(-13.7%)
Jun 2017
-
$8.94M(+1.0%)
$39.69M(-11.5%)
Mar 2017
-
$8.85M(+6.1%)
$44.85M(-3.6%)
Dec 2016
$46.53M(+50.9%)
$8.34M(-38.4%)
$46.53M(-1.1%)
Sep 2016
-
$13.56M(-3.9%)
$47.03M(+10.6%)
Jun 2016
-
$14.10M(+33.9%)
$42.54M(+19.7%)
Mar 2016
-
$10.53M(+18.9%)
$35.53M(+15.2%)
Dec 2015
$30.84M(+54.8%)
$8.85M(-2.3%)
$30.84M(+14.0%)
Sep 2015
-
$9.06M(+27.8%)
$27.05M(+18.9%)
Jun 2015
-
$7.09M(+21.3%)
$22.75M(+6.0%)
Mar 2015
-
$5.84M(+15.5%)
$21.46M(+7.7%)
Dec 2014
$19.93M(+34.5%)
$5.06M(+6.3%)
$19.93M(+5.2%)
Sep 2014
-
$4.76M(-18.1%)
$18.95M(+5.0%)
Jun 2014
-
$5.81M(+34.8%)
$18.05M(+11.0%)
Mar 2014
-
$4.31M(+5.6%)
$16.26M(+9.7%)
Dec 2013
$14.82M(+46.1%)
$4.08M(+5.8%)
$14.82M(+12.2%)
Sep 2013
-
$3.86M(-3.9%)
$13.21M(+15.0%)
Jun 2013
-
$4.01M(+39.8%)
$11.49M(+15.5%)
Mar 2013
-
$2.87M(+16.1%)
$9.95M(-1.1%)
Dec 2012
$10.14M(-7.0%)
$2.47M(+15.8%)
$10.06M(+5.2%)
Sep 2012
-
$2.13M(-13.6%)
$9.56M(-5.9%)
Jun 2012
-
$2.47M(-17.3%)
$10.16M(-7.9%)
Mar 2012
-
$2.98M(+51.2%)
$11.03M(+1.2%)
Dec 2011
$10.90M(+0.9%)
$1.97M(-27.9%)
$10.90M(-2.7%)
Sep 2011
-
$2.74M(-18.0%)
$11.20M(-0.9%)
Jun 2011
-
$3.34M(+17.1%)
$11.31M(+1.7%)
Mar 2011
-
$2.85M(+25.2%)
$11.12M(+2.9%)
Dec 2010
$10.80M
$2.28M(-19.9%)
$10.80M(-8.4%)
DateAnnualQuarterlyTTM
Sep 2010
-
$2.84M(-9.7%)
$11.79M(-3.0%)
Jun 2010
-
$3.15M(+24.2%)
$12.16M(+5.1%)
Mar 2010
-
$2.54M(-22.4%)
$11.57M(-3.0%)
Dec 2009
$11.93M(+7.6%)
$3.27M(+1.9%)
$11.93M(-1.2%)
Sep 2009
-
$3.21M(+25.2%)
$12.08M(+19.2%)
Jun 2009
-
$2.56M(-11.4%)
$10.13M(-5.6%)
Mar 2009
-
$2.89M(-15.3%)
$10.74M(-3.2%)
Dec 2008
$11.09M(-20.6%)
$3.42M(+170.0%)
$11.09M(+19.5%)
Sep 2008
-
$1.26M(-60.0%)
$9.28M(-21.7%)
Jun 2008
-
$3.17M(-2.4%)
$11.85M(-5.3%)
Mar 2008
-
$3.24M(+102.5%)
$12.52M(-9.8%)
Dec 2007
$13.96M(+23.7%)
$1.60M(-58.3%)
$13.88M(-3.4%)
Sep 2007
-
$3.84M(+0.2%)
$14.36M(+7.7%)
Jun 2007
-
$3.83M(-16.6%)
$13.33M(+4.1%)
Mar 2007
-
$4.60M(+120.4%)
$12.81M(+16.8%)
Dec 2006
$11.29M(-25.4%)
$2.09M(-25.9%)
$10.97M(-0.1%)
Sep 2006
-
$2.81M(-15.1%)
$10.98M(+0.8%)
Jun 2006
-
$3.31M(+20.2%)
$10.90M(-7.0%)
Mar 2006
-
$2.76M(+31.8%)
$11.72M(-22.6%)
Dec 2005
$15.14M(-54.2%)
$2.09M(-23.4%)
$15.14M(-31.5%)
Sep 2005
-
$2.73M(-34.0%)
$22.10M(-28.5%)
Jun 2005
-
$4.14M(-33.1%)
$30.92M(-10.1%)
Mar 2005
-
$6.18M(-31.7%)
$34.40M(+4.2%)
Dec 2004
$33.03M(+110.0%)
$9.05M(-21.7%)
$33.03M(+17.7%)
Sep 2004
-
$11.55M(+51.7%)
$28.07M(+37.4%)
Jun 2004
-
$7.62M(+58.4%)
$20.43M(+23.5%)
Mar 2004
-
$4.81M(+17.5%)
$16.54M(+5.2%)
Dec 2003
$15.72M(-26.9%)
$4.09M(+4.5%)
$15.73M(-0.7%)
Sep 2003
-
$3.91M(+5.0%)
$15.84M(-2.6%)
Jun 2003
-
$3.73M(-6.7%)
$16.27M(-11.1%)
Mar 2003
-
$4.00M(-5.0%)
$18.31M(-14.8%)
Dec 2002
$21.50M(+16.3%)
$4.21M(-3.1%)
$21.50M(-5.5%)
Sep 2002
-
$4.34M(-24.7%)
$22.75M(-2.1%)
Jun 2002
-
$5.77M(-19.8%)
$23.24M(+4.7%)
Mar 2002
-
$7.19M(+31.9%)
$22.20M(+20.0%)
Dec 2001
$18.49M(+215.7%)
$5.45M(+12.8%)
$18.49M(+14.6%)
Sep 2001
-
$4.83M(+2.2%)
$16.14M(+33.1%)
Jun 2001
-
$4.73M(+35.7%)
$12.13M(+39.4%)
Mar 2001
-
$3.48M(+12.6%)
$8.70M(+48.5%)
Dec 2000
$5.86M(+144.1%)
$3.09M(+276.4%)
$5.86M(+74.1%)
Sep 2000
-
$822.00K(-36.9%)
$3.37M(+0.7%)
Jun 2000
-
$1.30M(+103.1%)
$3.34M(+31.6%)
Mar 2000
-
$641.00K(+6.8%)
$2.54M(+5.9%)
Dec 1999
$2.40M(-4.0%)
$600.00K(-25.0%)
$2.40M(0.0%)
Sep 1999
-
$800.00K(+60.0%)
$2.40M(+9.1%)
Jun 1999
-
$500.00K(0.0%)
$2.20M(-8.3%)
Mar 1999
-
$500.00K(-16.7%)
$2.40M(0.0%)
Dec 1998
$2.50M(+4.2%)
$600.00K(0.0%)
$2.40M(+4.3%)
Sep 1998
-
$600.00K(-14.3%)
$2.30M(0.0%)
Jun 1998
-
$700.00K(+40.0%)
$2.30M(+4.5%)
Mar 1998
-
$500.00K(0.0%)
$2.20M(-4.3%)
Dec 1997
$2.40M(+26.3%)
$500.00K(-16.7%)
$2.30M(-4.2%)
Sep 1997
-
$600.00K(0.0%)
$2.40M(+14.3%)
Jun 1997
-
$600.00K(0.0%)
$2.10M(+5.0%)
Mar 1997
-
$600.00K(0.0%)
$2.00M(+11.1%)
Dec 1996
$1.90M
$600.00K(+100.0%)
$1.80M(+50.0%)
Sep 1996
-
$300.00K(-40.0%)
$1.20M(+33.3%)
Jun 1996
-
$500.00K(+25.0%)
$900.00K(+125.0%)
Mar 1996
-
$400.00K
$400.00K

FAQ

  • What is Novavax annual SGA?
  • What is the all time high annual SGA for Novavax?
  • What is Novavax annual SGA year-on-year change?
  • What is Novavax quarterly SGA?
  • What is the all time high quarterly SGA for Novavax?
  • What is Novavax quarterly SGA year-on-year change?
  • What is Novavax TTM SGA?
  • What is the all time high TTM SGA for Novavax?
  • What is Novavax TTM SGA year-on-year change?

What is Novavax annual SGA?

The current annual SGA of NVAX is $337.19M

What is the all time high annual SGA for Novavax?

Novavax all-time high annual SGA is $488.69M

What is Novavax annual SGA year-on-year change?

Over the past year, NVAX annual SGA has changed by -$131.76M (-28.10%)

What is Novavax quarterly SGA?

The current quarterly SGA of NVAX is $48.09M

What is the all time high quarterly SGA for Novavax?

Novavax all-time high quarterly SGA is $161.66M

What is Novavax quarterly SGA year-on-year change?

Over the past year, NVAX quarterly SGA has changed by -$38.71M (-44.60%)

What is Novavax TTM SGA?

The current TTM SGA of NVAX is -$19.23B

What is the all time high TTM SGA for Novavax?

Novavax all-time high TTM SGA is -$22.50M

What is Novavax TTM SGA year-on-year change?

Over the past year, NVAX TTM SGA has changed by -$19.68B (-4439.19%)
On this page